Conference & Meetings World Supplements Canada Supplement - Page 13

Montréal centre of its kind in the world dedicated to the principles of Open Science, an initiative to make all data and research available on a global level • Montréal was first in mapping the Primary Somatosensory Cortex • First city to develop a comprehensive repository of brain imaging, cellular, clinical, demographic, genetic and clinical data and samples from patients with neurological disorders • First city to offer a Neuroscience Nursing programme • First to introduce and develop Electroencephalography (EEG) • Major neuroimaging technologies including CAT, PET and MRI were first used in Canada at the Neuro. A champion of pharmaceutical R&D A subsidiary of the world’s largest biopharmaceutical company, Pfizer Canada employs 2,300 individuals across Canada and, since 2000, Pfizer Canada has invested CAD$1bn in R&D. “Even though Pfizer Canada focuses on R&D, it has never maintained its own research centres. We have always preferred conducting studies in partnership with specialised public and private sector organisations, an approach that has lately become the industry standard. I believe that this is an effective model that ensures the relevance and durability of Greater Montréal’s ecosystem,” said Ghislain Boudreau, the company's Vice-President of Public Affairs and Stakeholder Relations. Montreal has clearly leveraged the thinking and mentality of the start-up sector to neuroscience research to advance research and accelerate breakthroughs. Coming conferences In the neuroscience field alone, there is an impressive array of big conference business lined up for the city, including: • The Cognitive Science Society’s 41st Annual Meeting, 2019, 1,200 delegates • The International Society for Neurochemistry’s 27th ISN Congress 2019, 1,200 delegates • The North American Neuroendrocrine Tumour Society’s 2020 NANETS Annual Multidisplinary NET, 300 delegates • The Organisation for Human Brain Mapping’s 2020 Annual Conference, 2,500 delegates • The Canadian Neurological Sciences Federation’s 2022 Annual Congress, 500 delegates • The Canadian Association for Neuroscience’s 2023 Annual Meeting, 700 delegates Greater Montréal’s LSHT industry represents: Montréal has accumulated a critical mass of Life Science and Health Technology (LSHT) leaders and students, as well as: World-class companies operating in four subsectors: pharmaceuticals, health technologies, biotechnology and contract manufacturing/research 45,000 jobs in 600 facilities 6th among North America’s largest metropolitan areas in LSHT job concentration in 2011 27,000 students enrolled in LSHT-related university programmes in 2010 (Fall semester) and there were 6,300 graduates that year Research and development expertise (R&D): Above: The Montr é al McConnell Brain Imaging Centre Over 12,000 researchers and specialists working in approximately 300 public research organisations in 2011 Internationally recognised areas of excellence: aging, neuroscience and mental health, cancer, cardiovascular and metabolic disease, genetics, genomics, proteomics, etc. Above: Ghislain Boudreau, Pfizer Canada Vice-President of Public Affairs and Stakeholder Relations CAD$1.8bn in awards and grants from the Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC) between 2006 and 2011 – the highest in Canada. CONFERENCE & MEETINGS WORLD 13